E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/30/2018 in the Prospect News Structured Products Daily.

New Issue: Credit Suisse sells $1.54 million 8.84% contingent coupon callables tied to index, funds

By Susanna Moon

Chicago, Jan. 30 – Credit Suisse AG, London branch priced $1.54 million of contingent coupon callable yield notes due July 26, 2021 linked to the least performing of S&P 500 index, the SPDR S&P Biotech exchange-traded fund and the United States Oil Fund, LP, according to a 424B2 filing with the Securities and Exchange Commission.

The notes pay a contingent quarterly coupon at an annualized rate of 8.84% if each underlying component closes at or above its 60% coupon barrier on the observation date for that quarter.

The notes are callable at par on any interest payment date after one year.

The payout at maturity will be par unless any underlying component finishes below its 50% knock-in level, in which case investors will be fully exposed to any losses of the worst performing index or fund.

Credit Suisse Securities (USA) LLC is the agent.

Issuer:Credit Suisse AG, London branch
Issue:Contingent coupon callable yield notes
Underlying assets:S&P 500 index, SPDR S&P Biotech ETF and United States Oil Fund, LP
Amount:$1,539,000
Maturity:July 26, 2021
Contingent coupon:8.84% annualized, payable quarterly if each underlying component closes at or above 60% coupon barrier on observation date for that quarter
Price:Par
Payout at maturity:If each underlying component finishes at or above knock-in, par; otherwise, 1% loss per 1% drop of worst performing index or fund
Call option:At par on any interest payment date beginning Jan. 24, 2019
Initial levels:2,810.30 for S&P, $88.92 for biotech fund and $12.72 for oil fund
Coupon barriers:1,686.18 for S&P, $53.352 for biotech fund and $7.632 for oil fund; 60% of initial levels
Knock-in levels:1,405.15 for S&P, $44.46 for biotech fund and $6.36 for oil fund; 50% of initial levels
Pricing date:Jan. 19
Settlement date:Jan. 24
Agent:Credit Suisse Securities (USA) LLC
Fees:0.75%
Cusip:22550W6T9

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.